Supraglottic jet oxygenation and ventilation - A novel ventilation technique

Area of Science:

• Anesthesiology
• Respiratory Medicine
• Critical Care

Background:

• Supraglottic jet oxygenation and ventilation (SJOV) is an emerging minimally invasive technique.
• It aims to maintain physiological oxygen (PaO2) and carbon dioxide (PaCO2) levels.
• Current reported maximum duration of use is 45 minutes.

Purpose of the Study:

• To review evidence on SJOV's oxygenation and ventilation capabilities.
• To compare SJOV with other supraglottic oxygenation and ventilation devices.
• To assess SJOV's indications, airway patency, and complication profile.

Main Methods:

• Review of existing literature on SJOV.
• Comparison of SJOV with alternative supraglottic airway devices.
• Analysis of oxygenation, ventilation, and complication data.

Main Results:

• SJOV demonstrates superior oxygenation maintenance compared to nasal oxygenation.
• It allows for EtCO2 monitoring, a key advantage.
• High success rates in securing airway access, even in difficult cases (CLIII).
• Potential complications are limited to minor issues like nasal bleeding and sore throat.
• No severe barotrauma has been reported.

Conclusions:

• SJOV is a safe and effective method for oxygenation and ventilation.
• It offers significant advantages over nasal oxygenation, including EtCO2 monitoring and reliable airway access.
• Further research may explore longer durations of SJOV use and its application in diverse clinical scenarios.